KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 141 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $5,434,000 | -25.3% | 426,849 | -17.0% | 0.59% | -32.7% |
| Q4 2014 | $7,279,000 | +13.9% | 514,445 | +10.7% | 0.87% | +28.9% |
| Q3 2014 | $6,391,000 | -53.4% | 464,795 | -47.9% | 0.68% | -48.8% |
| Q2 2014 | $13,719,000 | -8.3% | 892,011 | +1.6% | 1.32% | -12.7% |
| Q1 2014 | $14,958,000 | -10.4% | 877,875 | -31.9% | 1.52% | +3.0% |
| Q4 2013 | $16,701,000 | +55.8% | 1,289,711 | +21.5% | 1.47% | +17.3% |
| Q3 2013 | $10,721,000 | +29.8% | 1,061,426 | -4.0% | 1.26% | +31.9% |
| Q2 2013 | $8,257,000 | – | 1,105,266 | – | 0.95% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 1,605,800 | $16,026,000 | 4.65% |
| Baupost Group | 25,791,678 | $257,401,000 | 4.29% |
| 1492 Capital Management LLC | 264,297 | $2,638,000 | 1.67% |
| Cormorant Asset Management, LP | 826,000 | $8,243,000 | 1.10% |
| FALCON POINT CAPITAL, LLC | 251,137 | $2,506,000 | 0.85% |
| OAK RIDGE INVESTMENTS LLC | 3,291,711 | $32,851,000 | 0.70% |
| Knoll Capital Management, LLC | 200,000 | $1,996,000 | 0.64% |
| Rhenman & Partners Asset Management AB | 534,000 | $5,329,000 | 0.64% |
| Old West Investment Management, LLC | 79,667 | $795,000 | 0.55% |
| THREE BAYS CAPITAL LP | 1,284,000 | $12,814,000 | 0.53% |